FINANCIAL INSTRUMENTS

3 Months Ended

May. 31, 2015

NOTE 2 – FINANCIAL INSTRUMENTS

Cash, Cash Equivalents and Marketable Securities

The following table summarizes the Company's cash and marketable securities as of May 31, 2015 using the hierarchy described in Note 1 under the heading “Fair Value Measurements” (in thousands):

								Balance Sheet Classification
								of Fair Value
			Unrealized					Cash and		Short-Term		Long-Term
	Adjusted		Gains			Fair		Cash		Marketable		Marketable
	Cost		(Losses)			Value		Equivalents		Securities		Securities
Cash	$	3,969	$	-		$	3,969	$	3,969	$	-	$	-

Level 2:
Repurchase agreements		122,000		-			122,000		112,000		10,000		-
Commercial paper		83,421		(88	)		83,333		461		57,591		25,281

Total	$	209,390	$	(88	)	$	209,302	$	116,430	$	67,591	$	25,281

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details